The impact of patient selection on long-term outcomes of left-ventricular assist device implantation as destination therapy for end-stage heart failure

被引:2
|
作者
Lietz, K. [1 ]
Long, J. [2 ,3 ]
Kfoury, A. G. [2 ,3 ]
Slaughter, M. S. [4 ,5 ]
Silver, M. A. [4 ,5 ]
Milano, C. A. [6 ,7 ]
Rogers, J. [6 ,7 ]
Miller, L. W. [1 ]
机构
[1] Univ Minnesota, Div Cardiovasc, Minneapolis, MN 55455 USA
[2] LDS Hosp, Div Cardiol, Salt Lake City, UT USA
[3] LDS Hosp, Div Cardiothorac Surg, Salt Lake City, UT USA
[4] Advocate Christ Med Ctr, Div Cardiol, Oak Lawn, IL USA
[5] Advocate Christ Med Ctr, Div Cardiothorac Surg, Oak Lawn, IL USA
[6] Duke Univ, Med Ctr, Div Cardiol, Durham, NC USA
[7] Duke Univ, Med Ctr, Div Cardiothorac Surg, Durham, NC USA
来源
关键词
D O I
10.1016/j.healun.2005.11.261
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
251
引用
收藏
页码:S131 / S131
页数:1
相关论文
共 50 条
  • [31] The role of left ventricular assist device therapy for patients with end-stage heart failure - serbian experience
    Nestorovic, E. Emilija
    Milic, N.
    Putnik, S.
    Terzic, D.
    Ristic, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 83 - 83
  • [32] TNFα in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device
    Bruggink, A. H.
    van Oosterhout, M. F. M.
    De Jonge, N.
    Gmelig-Meyling, F. H. J.
    De Weger, R. A.
    [J]. TRANSPLANT IMMUNOLOGY, 2008, 19 (01) : 64 - 68
  • [33] Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation
    Abdelshafy, Mahmoud
    Elsherbini, Hagar
    Elkoumy, Ahmed
    Simpkin, Andrew J.
    Elzomor, Hesham
    Caliskan, Kadir
    Soliman, Osama
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [34] Does left ventricular assist device implantation modulate the cardiac cell apoptosis in end-stage heart failure?
    Prescimone, T.
    Caruso, R.
    Campolo, J.
    Caselli, C.
    Cabiati, M.
    Boroni, C.
    Del Ry, S.
    Parodi, O.
    Giannessi, D.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 81 - 81
  • [35] Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results
    Perri, Gianluigi
    Filippelli, Sergio
    Adorisio, Rachele
    Iacobelli, Roberta
    Iodice, Francesca
    Testa, Giuseppina
    Paglietti, Maria Giovanna
    D'Amario, Domenico
    Massetti, Massimo
    Amodeo, Antonio
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (03): : 669 - 674
  • [36] Impact of Contemporary Ventricular Assist Device Therapy on Renal Outcomes in End Stage Heart Failure
    Xu, P. Z.
    Wu, S.
    Tun, H.
    Adenuga, G.
    Fong, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S473 - S474
  • [37] Implanting left ventricular assist device in end-stage heart failure with massive ventricular aneurysm
    Yao, Shaowen
    Qin, Yannv
    Yue, Jiarui
    Lu, Shichun
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (07) : 3332 - 3334
  • [38] LONG-TERM IMPLANTABLE LEFT-VENTRICULAR ASSIST DEVICES FOR OUTPATIENT THERAPY OF PATIENTS WITH END-STAGE HEART-DISEASE - AN ALTERNATIVE TO TRANSPLANTATION
    OZ, MC
    GOLDSTEIN, DJ
    ASHTON, RC
    CATANESE, KA
    DASSE, KA
    LEVIN, HR
    ROSE, EA
    [J]. CIRCULATION, 1995, 92 (08) : 1802 - 1802
  • [39] WHAT CAN THE PATIENT WITH CHRONIC END-STAGE HEART FAILURE EXPECT FROM A LONG-TERM LEFT VENTRICULAR ASSIST DEVICE? A SYSTEMATIC REVIEW OF CURRENT EVIDENCE
    Sas, G.
    Lambert, L. J.
    Boothroyd, L. J.
    Ducharme, A.
    Charbonneau, E.
    Carrier, M.
    Cecere, R.
    Guertin, J. R.
    Morin, J. E.
    Bogaty, P.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S337 - S338
  • [40] Short-term Results of Heartmate 3 Ventricular Assist Device Implantation for End-Stage Heart Failure
    Ozturk, P.
    Ertugay, S.
    Sahutoglu, C.
    Engin, C.
    Nalbantgil, S.
    Yagdi, T.
    Ozbaran, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2017, 49 (03) : 599 - 602